When was INIA Biosciences founded?

INIA Biosciences was founded in 2020 and raised its 1st funding round 4 years after it was founded.

Where is INIA Biosciences located?

INIA Biosciences is headquartered in Boston, United States.

Who is the current CEO of INIA Biosciences?

Shen Ning of INIA Biosciences. They have also founded 1 company.

How many employees does INIA Biosciences have?

As of Mar 31, 2026, the latest employee count at INIA Biosciences is 5.

Is INIA Biosciences a funded company?

INIA Biosciences is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Mar 15, 2024.

When was the latest funding round of INIA Biosciences?

INIA Biosciences' latest funding was a $***** Grant (prize money) round on Feb 24, 2025, with participation from 1 investor.

Where does INIA Biosciences rank among its competitors?

INIA Biosciences ranks 8th amongst 18 active competitors, of which 7 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Santersus, which secured an undisclosed amount in Dec, 2025.

Who are the top competitors of INIA Biosciences?

INIA Biosciences' top competitors include SetPoint Medical, Cel-Sci and Boomerang Medical. Among them, Santersus secured the most recent funding round in December, 2025.

INIA Biosciences - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of diagnostic devices to treat inflammatory diseases. The company leverages non-invasive ultrasound with novel diagnostic sensing to treat chronic diseases.

Website: www.iniabiosciences.com/
Social

Key Metrics

Founded Year

2020

Location

Boston, United States

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Feb 24, 2025, $*****

Investors

National Science Foundation

Ranked

8^th among 18 active competitors

Employee Count

5 as on Mar 31, 2026

Similar Companies

SetPoint Medical & 19 more

View INIA Biosciences' full profile

INIA Biosciences has raised funding over 2 rounds. Its first funding round was on Mar 15, 2024. Its latest funding round was a Grant (prize money) round on Feb 24, 2025 for $*****. 1 investor participated in its latest round. INIA Biosciences has 1 institutional investor.

Here is the list of recent funding rounds of INIA Biosciences:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 24, 2025	3632105	Grant (prize money)	8921147	2025547	2415483	2370431
Mar 15, 2024	5431646	Grant (prize money)	1907530	9354971	5345984	National Science Foundation

Access funding benchmarks and valuations. Sign up today!

View details of INIA Biosciences's funding rounds and investors

The founders of INIA Biosciences are Dragana Savic and Shen Ning. Shen Ning is the CEO of INIA Biosciences.

Here are the details of INIA Biosciences' key team members:

Dragana Savic: Co-Founder of INIA Biosciences.
Shen Ning: Co-Founder & CEO of INIA Biosciences.

View details of INIA Biosciences's Founder profiles and Board Members

INIA Biosciences' employee count trend

INIA Biosciences has 5 employees as of Mar 26. Here is INIA Biosciences's employee count trend over the years:

Employee count trend for INIA Biosciences

Uncover INIA Biosciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of INIA Biosciences include SetPoint Medical, Cel-Sci and Boomerang Medical. Here is the list of Top 10 competitors of INIA Biosciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	SetPoint Medical 2006, Santa Clarita (United States), Series F	Developer of implantable neuromodulation devices for inflammatory diseases	$388M	Viking Global Investors, Flare Capital Partners ... & 32 others	64/100
2nd	Cel-Sci 1983, Vienna (United States), Public	Developer of immunotherapy products for the treatment of cancer and infectious diseases	-	Alpha Capital Partners, Midsummer Capital ... & 7 others	58/100
3rd	Boomerang Medical 2021, Mountain View (United States), Series B	Bioelectronic device technology for the treatment of autoimmune diseases	$35M	Arboretum Ventures, Hatteras Venture Partners	48/100
4th	Hippo Dx 2020, Belgium, Series A	Developer of a medical device to provide an automated test that detects allergies	$4.67M	LRM, AllerFund & 1 others	40/100
5th	RegenLab 2003, Brooklyn (United States), Funding Raised	Provider of medical devices to develop cellular therapies	-	-	38/100
6th	Santersus 2019, Maur (Switzerland), Series A	Developer of blood purification device used in sepsis, autoimmune diseases, cancer and Covid-19	-	Norcliffe Capital, Terumo Medical	36/100
7th	Impulse Biomedical 2018, Cape Town (South Africa), Seed	Developer of a device for adrenaline auto-injection	-	Futuregrowth, Launch Africa & 2 others	31/100
8th	INIA Biosciences 2020, Boston (United States), Funding Raised	Developer of diagnostic devices to treat inflammatory diseases	-	National Science Foundation	32/100
9th	Labseed 2009, Lausanne (Switzerland), Seed	Developer of technology to suppress capsular contraction	$115K	Venture Kick, Venturelab	28/100
10th	Therakos 1984, West Chester (United States), Acquired	Photopheresis systems and solutions for cutaneous T-cell lymphoma treatment	-	Prospect Capital	28/100